ClinicalTrials.gov
public full text
Public Domain
Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia
This is a hospital-based interventional prospective study. Patients with clinical keratoconus or LASIK keratectasia presenting to the Singapore National Eye Centre who meet the eligibility criteria are recruited for this study. The aim of the study is to assess the safety and efficacy of riboflavin-UVA induced cross-linking treatment for corneal ectasia
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study#846886
- Corneal Collagen Cross-linking With Hypotonic Riboflavin in Corneas Thinner Than 400 Microns#992526
- Surface Ablation With Corneal Cross Linking in Mild Keratoconus#1009363
- Demographics and Clinical Characteristics of Paediatric Intraocular Inflammation in Singapore#902993
- Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus#1104250
Record · ID 1007252
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive